Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg
CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg buy - large image1
CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg buy - image1
CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg buy - image2
CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg buy - image3
CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg buy - image4
CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg buy - image5
CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg buy - image6

CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg

6905 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

CQ

Packaging:

10mg*10vials

Price valid (until):

2025-12-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,copper peptide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

                                                                              Sales manager: Coco
                                                                        whatsapp:+86 18333957523
                                                                        Email:coco@xtzhongsheng.com


       Product Detail   


    Items Specifications
    CAS NO  2381089-83-2
    USE Weight loss peptide raw material
    appearance White powder

    MOTS-c: A Mitochondria-Derived Metabolic Regulatory Peptide

    I. Basic Information

    MOTS-c, short for mitochondrial open reading frame of the 12S rRNA - c, is a mitochondria - derived peptide (MDP) encoded by mitochondrial DNA. Composed of 16 amino acids, its uniqueness lies in that, unlike most peptides encoded by nuclear genes, it originates from mitochondrial genes. This endows it with special biological functions and metabolic regulatory roles.

    II. Mechanism of Action

    1. Activation of the AMPK Pathway: MOTS-c can induce the accumulation of the endogenous AMP analog AICAR, thereby activating AMP - activated protein kinase (AMPK). AMPK is a central regulator of cellular energy homeostasis. Once activated, it promotes cellular glucose uptake and fatty acid oxidation, enhances insulin sensitivity, and regulates blood glucose levels. For example, in cell models with insulin resistance, after treatment with MOTS-c, the cells' response to insulin is enhanced, and glucose uptake increases significantly, as if opening a "fast lane" for cells to take in glucose.

    2. Inhibition of the Folate Cycle and De Novo Purine Synthesis: By inhibiting the folate cycle and its associated de novo purine synthesis, it indirectly regulates cellular energy metabolism and physiological functions. However, the specific molecular details are still under in - depth research.

    3. Regulation of Gene Expression: MOTS-c can translocate to the nucleus and affect the expression of genes related to mitochondrial biogenesis and metabolic regulation, especially under metabolic stress conditions. This is of great significance for maintaining the stability of the intracellular environment and normal metabolic functions.

    III. Physiological Functions

    1. Metabolic Improvement:

    ◦ Blood Glucose Regulation: It effectively promotes glucose uptake in skeletal muscles, enhances insulin sensitivity, and thus reduces blood glucose levels. It has potential therapeutic value for metabolic diseases such as diabetes.

    ◦ Lipid Metabolism Regulation: It reduces lipid droplet deposition. On one hand, it inhibits the synthesis of adipocyte - related genes; on the other hand, it increases the activation of brown fat with faster metabolism and reduces the accumulation of white fat with slower metabolism, thereby promoting lipid metabolism.

    2. Cell Protection: When cells face stress such as oxidative stress and nutrient deficiency, the expression level of MOTS-c changes, and it activates the intracellular stress signaling pathway. For instance, under oxidative stress, it can induce the expression of antioxidant enzymes, scavenge excessive free radicals, reduce oxidative damage, and protect the structural and functional integrity of cells.

    3. Anti - aging: It regulates the senescent phenotype of cells, improves cellular metabolic and stress response capabilities, and delays cellular senescence. In model organism experiments, increasing the level of MOTS-c can extend the lifespan of organisms, possibly by activating a series of anti - aging genes and signaling pathways.

    4. Other Functions: In animal model studies, MOTS-c has also shown effects such as antinociception, anti - inflammation, prevention of islet destruction in autoimmune diabetes, improvement of exercise endurance, reduction of obesity and insulin resistance, and alleviation of the progression of diseases such as osteoporosis.

    IV. Application Prospects

    1. Drug Development: Given its significant effects on metabolic regulation and disease improvement, MOTS-c is highly likely to become a novel drug target for the treatment of metabolic disorders such as diabetes and obesity, as well as for anti - aging. By developing drugs that regulate the level of MOTS-c or mimic its functions, new breakthroughs in the treatment of these diseases are expected.

    2. Health Product Development: Based on its anti - aging and metabolic improvement functions, developing health products with MOTS-c as the core ingredient can meet people's needs for health and anti - aging. However, most current related applications are still in the laboratory research stage. There is still a long way to go before clinical application and commercialization of products, and a large number of clinical trials are required to verify its safety and effectiveness.

    V. Product Parameters (Taking Research Products as an Example)

    1. Peptide Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg

    2. Molecular Weight: 2174.62

    3. Molecular Formula: C101H152N28O22S2

    4. Purity: Usually, HPLC purity > 95% or higher (may vary among different suppliers) to ensure the accuracy and reliability of research experimental results.

    5. Solubility: Soluble in water, facilitating the preparation of various solution systems required for experiments.

    6. Appearance: Generally, it is a lyophilized powder solid, which is easy to store and transport.

    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 1
    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 2
    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 3
    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 4


    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 5
    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 6
    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 7


    Company Profile   


    Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.

    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 8
    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 9
    Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 10 Shop CAS no 1627580-64-6 Best Price and 99.9 High Purity MOST C 10mg-Detailed Image 11
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,copper peptide

    Location:

    room 102, No. 60-20, Gongnong Street, Xiangya Road Subdistrict, Kaifu District, Changsha City, Hunan Province, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment

    Average lead Time:

    2

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    Changsha Caoquan Technology Co., Ltd

    Changsha Caoquan Technology Co., Ltd was established in 2020 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

    Its core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering and protein engineering. The company has built a 3,300-square-meter recombinant drug research and development center in Shibei, Yuelu District, Changsha City. It has a complete pharmaceutical engineering, preparation and quality research system and talent team, and has built a GMP workshop to meet the international market API supply and CDMO services.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.

  • Inquiry History
    6905 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.